- Home
- ACIU vs RDNW Comparison
ACIU vs RDNW Comparison
Compare ACIU & RDNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- RDNW
- Stock Information
- Founded
- ACIU 2003
- RDNW 2013
- Country
- ACIU Switzerland
- RDNW United States
- Employees
- ACIU N/A
- RDNW N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- RDNW EDP Services
- Sector
- ACIU Health Care
- RDNW Technology
- Exchange
- ACIU Nasdaq
- RDNW Nasdaq
- Market Cap
- ACIU 213.3M
- RDNW 202.9M
- IPO Year
- ACIU 2016
- RDNW N/A
- Fundamental
- Price
- ACIU $2.97
- RDNW $5.08
- Analyst Decision
- ACIU Strong Buy
- RDNW Hold
- Analyst Count
- ACIU 2
- RDNW 1
- Target Price
- ACIU $10.00
- RDNW $4.00
- AVG Volume (30 Days)
- ACIU 266.4K
- RDNW 62.6K
- Earning Date
- ACIU 11-04-2025
- RDNW 11-04-2025
- Dividend Yield
- ACIU N/A
- RDNW N/A
- EPS Growth
- ACIU N/A
- RDNW N/A
- EPS
- ACIU N/A
- RDNW N/A
- Revenue
- ACIU $5,482,957.00
- RDNW $1,095,200,000.00
- Revenue This Year
- ACIU N/A
- RDNW N/A
- Revenue Next Year
- ACIU $1,022.98
- RDNW $7.73
- P/E Ratio
- ACIU N/A
- RDNW N/A
- Revenue Growth
- ACIU N/A
- RDNW N/A
- 52 Week Low
- ACIU $1.43
- RDNW $1.46
- 52 Week High
- ACIU $4.00
- RDNW $7.06
- Technical
- Relative Strength Index (RSI)
- ACIU 44.78
- RDNW N/A
- Support Level
- ACIU $2.70
- RDNW N/A
- Resistance Level
- ACIU $3.13
- RDNW N/A
- Average True Range (ATR)
- ACIU 0.21
- RDNW 0.00
- MACD
- ACIU -0.05
- RDNW 0.00
- Stochastic Oscillator
- ACIU 32.50
- RDNW 0.00
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About RDNW RideNow Group Inc.
RideNow Group Inc is a USA-based online retailer that allows consumers and dealers both to Buy-Sell-Trade-Finance pre-owned motorcycles in an efficient, fast, transparent, and engaging experience.